Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Liminatus Pharma, Inc. - Class A Common Stock
(NQ:
LIMN
)
0.1694
-0.0766 (-31.14%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 22, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Liminatus Pharma, Inc. - Class A Common Stock
< Previous
1
2
3
4
Next >
Which stocks are experiencing notable movement on Friday?
↗
Today 15:00 EDT
Via
Chartmill
Unusual volume stocks in Friday's session
↗
Today 13:00 EDT
Via
Chartmill
Keep an eye on the top gainers and losers in Friday's session.
↗
Today 12:30 EDT
Via
Chartmill
Friday's session: gap up and gap down stocks
↗
Today 10:30 EDT
Via
Chartmill
Unusual volume stocks in Thursday's session
↗
February 05, 2026
Via
Chartmill
Discover the top movers in Friday's pre-market session.
↗
Today 8:30 EDT
Via
Chartmill
Liminatus Pharma Announces Nasdaq Delisting Notification
May 21, 2026
From
Liminatus Pharma Inc.
Via
GlobeNewswire
Most active stocks in Thursday's session
↗
May 21, 2026
Via
Chartmill
Here are the top movers in Thursday's session.
↗
May 21, 2026
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
May 21, 2026
Via
Chartmill
What's going on in today's pre-market session
↗
May 21, 2026
Via
Chartmill
Liminatus Pharma Announces Proposed Merger with InnocsAI to Expand Oncology Cell Therapy Pipeline
May 21, 2026
Transaction Adds Clinical and Preclinical CAR-T Programs Targeting Hematologic Malignancies and Solid Tumors
From
Liminatus Pharma Inc.
Via
GlobeNewswire
Which stocks are most active on Wednesday?
↗
April 15, 2026
These stocks are making the most noise in today's session. Stay tuned for the latest updates!
Via
Chartmill
Topics
Artificial Intelligence
Wondering what's happening in today's after-hours session?
↗
April 07, 2026
Via
Chartmill
Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody
March 17, 2026
From
Liminatus Pharma Inc.
Via
GlobeNewswire
Top movers analysis one hour before the close of the markets on 2026-02-17: top gainers and losers in today's session.
↗
February 17, 2026
Via
Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session.
↗
February 17, 2026
Via
Chartmill
Tuesday's session: gap up and gap down stocks
↗
February 17, 2026
Via
Chartmill
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering
February 17, 2026
From
Liminatus Pharma, Inc.
Via
GlobeNewswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
February 13, 2026
Via
Chartmill
Which stocks are experiencing notable movement on Wednesday?
↗
February 11, 2026
Via
Chartmill
On Wednesday, there are stocks with unusual volume. Let's take a look.
↗
February 11, 2026
Via
Chartmill
Top stock movements in today's session.
↗
February 11, 2026
Via
Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
February 11, 2026
Via
Chartmill
On Monday, there are stocks with unusual volume. Let's take a look.
↗
February 09, 2026
Via
Chartmill
Curious about the stocks that are showing activity after the closing bell on Friday?
↗
February 06, 2026
Via
Chartmill
Unusual volume stocks in Friday's session
↗
February 06, 2026
Via
Chartmill
Here are the top movers in Thursday's session.
↗
February 05, 2026
Via
Chartmill
Thursday's session: top gainers and losers
↗
February 05, 2026
Via
Chartmill
These stocks have an unusual volume in today's session
↗
February 04, 2026
Via
Chartmill
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.